FDA grants Breakthrough Device status to NET Recovery’s tACS wearable, aiming to curb cocaine and meth use and close a major treatment gap.
|Slideshows|December 18, 2018
Digital Psychiatry: 7 Trends in to Watch in 2019
Author(s)John Torous, MD, MBI
While no one can predict the future, it is clear that 2019 will be a transformative year for smartphone apps, sensors, chatbots, and much more. Here are 7 trends to follow.
Advertisement
Advertisement
Related to this article
How tuning body signals with closed-loop sound and chill tech may ease dissociation and anhedonia, offering drug-free add-ons to therapy.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
2
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
3
Positive Phase 2 Topline Results: Remlifanserin for the Treatment of Alzheimer Disease Psychosis
4
Searching for a New TMS Target in Schizophrenia, With Andrew Pines, MD
5